Search

everythinglearnresearchcommunity

for

Search:↓

imTA and pulse therapy are effective for alopecia areata with manageable side effects, but relapse rates need improvement.

Alopecia areata treatment varies, with no optimal method established yet.

Alopecia Areata affects 2% globally, with treatments like essential oils, garlic, and JAK inhibitors showing promise, but more research is needed.

Certain cytokines and growth factors can inhibit hair growth and may affect alopecia areata.

The conclusion is that an algorithm using trichoscopy helps diagnose different types of hair loss but may need updates and a biopsy if results are unclear.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

The AA-IGA scale reliably measures treatment success in alopecia areata by considering both clinician and patient views.

Myeloid-derived suppressor cells help control autoimmune cells and promote hair regrowth in alopecia areata.

Topical JAK inhibitors may help children with alopecia areata regrow hair.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

CD44 variant changes start alopecia areata, but don't maintain it.

Minoxidil and finasteride are effective for male hair loss, minoxidil for female hair loss, and various treatments like corticosteroids work for alopecia areata; treatment should be tailored to the individual.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

The document concludes that certain rats and mice are useful for studying hair loss in humans and testing treatments.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Methotrexate sometimes helps regrow hair in children with severe alopecia areata and is generally safe.

Stress might contribute to hair loss in alopecia areata.

Adalimumab may cause severe hair loss in some patients.

Alopecia areata is influenced by genetics and immune system factors, and better understanding could improve treatments.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

Alopecia areata greatly harms quality of life, causing emotional and social issues.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Trichohyalin may trigger the immune response causing alopecia areata.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Alopecia areata affects many in the US, impacting quality of life, with limited treatment options.

People with alopecia areata often have lower levels of vitamin D, zinc, and folate, but more research is needed to understand if supplements can help treat it.

PRP more effective than minoxidil 5% for treating alopecia areata.

New genetic discoveries may lead to better treatments for alopecia areata.

Alopecia areata patients have higher oxidative stress and lower antioxidant levels.